Assessment of Personalized Follow-up in Prevention of Type 2 Diabetes
Launched by RAMSAY GÉNÉRALE DE SANTÉ · Apr 5, 2022
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new way to help prevent type 2 diabetes (T2D) by providing personalized follow-up care. In France, many people may have diabetes without realizing it, and lifestyle choices like diet and inactivity can increase the risk. The study aims to find out if a coordinated, preventive approach can help catch early signs of diabetes and support people in making healthier choices before they develop the disease.
To participate, individuals need to be at least 18 years old and have a specific risk score indicating they are at higher risk for diabetes. Those who are already diagnosed with T2D, over 75 years old, or have serious health issues are not eligible. Participants will receive personalized follow-up and support, which may include guidance on diet and exercise, to help lower their risk of developing diabetes. This study is an important step in shifting from just treating diabetes to preventing it altogether.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient, male or female, over the age of 18
- • Patient with a FINDRISC score ≥10 points
- • Beneficiary of a French health insurance system
- • Patient having been informed and having given their consent free, enlightened and written
- Exclusion Criteria:
- • Patient over 75 years old
- • Patient already diagnosed with type 2 diabetes
- • Patient whose physical and/or psychological health is severely impaired, which according to the investigator may affect the compliance of the study participant.
- • Patient participating in another research
- • Patient in period of exclusion from another research always in progress at the time of inclusion.
- • Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by court order or administration.
- • Pregnant, breastfeeding or parturient women.
- • Patient hospitalized without consent
About Ramsay Générale De Santé
Ramsay Générale de Santé is a leading private healthcare provider in France, dedicated to delivering high-quality medical services and advancing healthcare through innovative clinical research. With a robust portfolio of hospitals and clinics, the organization focuses on improving patient outcomes by conducting rigorous clinical trials across various therapeutic areas. Committed to enhancing healthcare solutions, Ramsay Générale de Santé collaborates with healthcare professionals, researchers, and pharmaceutical companies to facilitate groundbreaking studies that contribute to medical knowledge and patient care advancements. Their emphasis on patient safety, ethical standards, and scientific integrity underscores their role as a trusted sponsor in the clinical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Biarritz, Aquitaine, France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials